- Home
- ACLX vs BVN Comparison
ACLX vs BVN Comparison
Compare ACLX & BVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- BVN
- Stock Information
- Founded
- ACLX 2015
- BVN 1953
- Country
- ACLX United States
- BVN Peru
- Employees
- ACLX N/A
- BVN N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- BVN Metal Mining
- Sector
- ACLX Health Care
- BVN Basic Materials
- Exchange
- ACLX Nasdaq
- BVN Nasdaq
- Market Cap
- ACLX 3.5B
- BVN 4.2B
- IPO Year
- ACLX 2022
- BVN 1996
- Fundamental
- Price
- ACLX $67.16
- BVN $16.70
- Analyst Decision
- ACLX Strong Buy
- BVN Buy
- Analyst Count
- ACLX 14
- BVN 2
- Target Price
- ACLX $111.42
- BVN $16.75
- AVG Volume (30 Days)
- ACLX 567.9K
- BVN 949.0K
- Earning Date
- ACLX 08-07-2025
- BVN 07-24-2025
- Dividend Yield
- ACLX N/A
- BVN 1.75%
- EPS Growth
- ACLX N/A
- BVN 2751.76
- EPS
- ACLX N/A
- BVN 1.90
- Revenue
- ACLX $76,809,000.00
- BVN $1,215,528,000.00
- Revenue This Year
- ACLX N/A
- BVN $11.64
- Revenue Next Year
- ACLX $112.68
- BVN $9.23
- P/E Ratio
- ACLX N/A
- BVN $8.78
- Revenue Growth
- ACLX N/A
- BVN 37.33
- 52 Week Low
- ACLX $47.86
- BVN $11.50
- 52 Week High
- ACLX $107.37
- BVN $17.71
- Technical
- Relative Strength Index (RSI)
- ACLX 59.84
- BVN 59.09
- Support Level
- ACLX $63.13
- BVN $16.34
- Resistance Level
- ACLX $67.83
- BVN $16.73
- Average True Range (ATR)
- ACLX 2.52
- BVN 0.41
- MACD
- ACLX 0.14
- BVN -0.05
- Stochastic Oscillator
- ACLX 90.30
- BVN 63.91
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About BVN Buenaventura Mining Company Inc.
Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.